Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
2008
2009
2010
Announcements
Articles
Articles and Publications
Campaign
Case Studies
Charge Capture and Pricing
Coding Integrity
Company
Consulting
Craneware Insights Articles
Education
Home
Journey
News & Events
Opportunities
Other
post
Press Releases
Products
Services
Testimonial
Trade Shows
Uncategorized
Uncategorized
Upcoming Events
Value Cycle
Webinars
White Papers

Has the AMA created new CPT codes related to COVID-19 antibody and virus testing?

Yes. On August 11, 2020, the AMA announced the creation of four new CPT codes related to COVID-19 testing; CPTs 86408, 86409, 0225U and 0226U. Per the AMA, CPTs 86408 and 86409 are to be used for COVID-19 neutralizing antibody screening (CPT 86408) and titer testing (CPT 86409) respectively. New PLA code 0225U is to be reported for the ePlex Respiratory Pathogen Panel 2 test developed by GenMark Diagnostics, while PLA code 0226U should be reported for the Tru-Immune test developed by Ethos Laboratories in partnership with GenScript USA. For additional information as well as clinical examples related to the use of the new codes, please review the CPT Assistant Article linked below.

As always, we caution that there will be a delay for both Medicare and private payers to establish a payment rate and update their claims processing systems to accept these new codes. To avoid claim rejections and denials we would advise checking with your individual MACs and/or commercial payers prior to claim submission to confirm code availability.

AMA CPT Assistant “Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) Laboratory Testing”:
https://www.ama-assn.org/system/files/2020-08/cpt-assistant-guide-coronavirus-august-2020.pdf